Min Yang
- Biological Psychiatry top 2%
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery 13
- Behavioral Neuroscience top 2%
- Biomedical Engineering top 1%
- Nanoplatforms for cancer theranostics 22
-
- Radiopharmaceutical Chemistry and Applications 29
- Monoclonal and Polyclonal Antibodies Research 13
-
- Peptidase Inhibition and Analysis 23
-
- Advanced Nanomaterials in Catalysis 12
-
- Advanced biosensing and bioanalysis techniques 12
-
- Lung Cancer Treatments and Mutations 12
- Co-authors
- Junjie YanDonghui PanXinyu WangXiaohong ChenYuping XuZhen GuQuli FanGuojun Chen
- Journals
- European Journal of Nuclear Medicine and Molecular Imaging (8 papers)Molecular Pharmaceutics (8 papers)RSC Advances (5 papers)
- Partner nations
- ChinaUnited StatesFiji
In The Last Decade
Min Yang
219 papers receiving 5.7k citations
Hit Papers
Peers
Comparison fields: 5 of 153
- Biological Psychiatry 233
- Biomaterials 836
- Behavioral Neuroscience 181
- Biomedical Engineering 1.9k
- Radiology, Nuclear Medicine and Imaging 873
Countries citing papers authored by Min Yang
This map shows the geographic impact of Min Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min Yang more than expected).
Fields of papers citing papers by Min Yang
This network shows the impact of papers produced by Min Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min Yang. The network helps show where Min Yang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Min Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 8 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 0 | |
| 8 | 2024 | 1 | |
| 9 | 2023 | 3 | |
| 10 | 2023 | 1 | |
| 11 | 2023 | 2 | |
| 12 | 2022 | 1 | |
| 13 | 2021 | 7 | |
| 14 | 2021 | 4 | |
| 15 | 2021 | 72 | |
| 16 | Long noncoding RNA ZFPM2-AS1 promotes the tumorigenesis of renal cell cancer via targeting miR-137 | 2020 | 9 |
| 17 | A pilot study of conformal radiotherapy combined with erlotinib-based multimodality therapy in newly diagnosed metastatic non-small-cell lung cancer. | 2015 | 2 |
| 18 | 2013 | 1 | |
| 19 | 2010 | 34 | |
| 20 | Effect of ganglioside on expression of synaptophysin p38 in rats after cerebral ischemic reperfusion | 2006 | 1 |
About Min Yang
Min Yang is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Biomaterials, having authored 230 papers that have together received 5.7k indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (29 papers), Peptidase Inhibition and Analysis (23 papers), Nanoplatforms for cancer theranostics (22 papers), Nanoparticle-Based Drug Delivery (13 papers), Monoclonal and Polyclonal Antibodies Research (13 papers), Advanced Nanomaterials in Catalysis (12 papers), Advanced biosensing and bioanalysis techniques (12 papers) and Lung Cancer Treatments and Mutations (12 papers). The work is most often cited by research in Biological Psychiatry (233 citations), Biomaterials (836 citations) and Behavioral Neuroscience (181 citations). Min Yang has collaborated with scholars based in China, United States and Fiji. Frequent co-authors include Junjie Yan, Donghui Pan, Xinyu Wang, Xiaohong Chen, Yuping Xu, Zhen Gu, Quli Fan, Guojun Chen, Yue Lü and Ruiping Zhang. Their work appears in journals such as European Journal of Nuclear Medicine and Molecular Imaging, Molecular Pharmaceutics, RSC Advances, Advanced Materials and Journal of Radioanalytical and Nuclear Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.